Japanese trading and pharmaceutical company Kowa Co Ltd said on Monday anti-parasite drug ivermectin showed an “antiviral effect” against omicron and other variants of coronavirus in joint non-clinical research.
For more coronavirus news, visit our dedicated page.
Kowa did not provide further details. The firm has been working with Kitasato University, a medical university in Tokyo.
Clinical trials evaluating the drug, which is used to treat parasites in animals and humans, are ongoing but promotion of the drug as a COVID-19 treatment has generated controversy
The drug is not approved for treatment of COVID-19 in Japan and the US Federal Drug Administration has repeatedly warned against its use.
Russia sees over 100,000 daily COVID-19 cases for first time
Canada truckers head for Ottawa to protest vaccine mandate
COVID-19 cases plateauing in parts of India but omicron still surges
Canada truckers head for Ottawa to protest vaccine mandateHundreds of Canadian truckers converged on Ottawa Friday for a major demonstration against vaccine mandates to cross the Canada-US border. Coming from ... World News
COVID-19 cases plateauing in parts of India but omicron still surgesIndian health officials said Thursday there were signs of COVID-19 infections plateauing in some parts of the country but cautioned that cases were ... World News
Russia sees over 100,000 daily COVID-19 cases for first timeRussia reported more than 100,000 daily coronavirus cases for the first time on Saturday as the country weathers a surge of infections driven by the ... World News